JEROME J. DVONCH - 29 Dec 2023 Form 4 Insider Report for Sonoma Pharmaceuticals, Inc. (SNOA)

Role
Interim CFO
Signature
/s/ Jerome Dvonch
Issuer symbol
SNOA
Transactions as of
29 Dec 2023
Net transactions value
$0
Form type
4
Filing time
29 Dec 2023, 17:24:22 UTC
Previous filing
13 Apr 2023
Next filing
21 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNOA Stock option (right to buy) Award +60,000 +104% 117,777 29 Dec 2023 Common Stock 60,000 $0.1800 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest one third each on 12/29/2024, 12/29/2025 and 12/29/2026, or upon change of control.
F2 The options were awarded and granted to Mr. Dvonch for services performed as part of the Company's annual grant of stock options.